Clinical Trials Browser

Phase 1/2 × Withdrawn × Aminolevulinic Acid × Clear all

NCT00977795 2019-09-10

A Study of the Specificity and Sensitivity of 5-ALA Fluorescence in Malignant Brain Tumors

Phase 1/2 Withdrawn

Brain Neoplasms, Glioblastoma, Glioma